These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 15478032)
21. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. White PC; Mune T; Agarwal AK Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789 [TBL] [Abstract][Full Text] [Related]
22. Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis. Claus R; Wagner A; Lambert T Exp Clin Endocrinol Diabetes; 2005 May; 113(5):262-7. PubMed ID: 15926111 [TBL] [Abstract][Full Text] [Related]
23. [From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids]. Levtchenko EN; Deinum J; Knoers NV; Hermus AR; Monnens LA; Lenders JW Ned Tijdschr Geneeskd; 2007 Mar; 151(12):692-4. PubMed ID: 17447595 [TBL] [Abstract][Full Text] [Related]
24. Alteration of the activity of the 11beta-hydroxysteroid dehydrogenase in pregnancy: relevance for the development of pregnancy-induced hypertension? Heilmann P; Buchheim E; Wacker J; Ziegler R J Clin Endocrinol Metab; 2001 Nov; 86(11):5222-6. PubMed ID: 11701681 [TBL] [Abstract][Full Text] [Related]
25. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency]. Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418 [TBL] [Abstract][Full Text] [Related]
26. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver. Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719 [TBL] [Abstract][Full Text] [Related]
27. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject. Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868 [TBL] [Abstract][Full Text] [Related]
28. 11beta-hydroxysteroid dehydrogenase and corticosteroid action in lyon hypertensive rats. Lloyd-MacGilp SA; Nelson SM; Florin M; Lo M; McKinnell J; Sassard J; Kenyon CJ Hypertension; 1999 Nov; 34(5):1123-8. PubMed ID: 10567193 [TBL] [Abstract][Full Text] [Related]
30. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome? Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270 [TBL] [Abstract][Full Text] [Related]
31. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension]. Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501 [TBL] [Abstract][Full Text] [Related]
32. 11 beta-Hydroxysteroid dehydrogenase. Stewart PM; Krozowski ZS Vitam Horm; 1999; 57():249-324. PubMed ID: 10232052 [TBL] [Abstract][Full Text] [Related]
33. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients. Henschkowski J; Stuck AE; Frey BM; Gillmann G; Dick B; Frey FJ; Mohaupt MG Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572 [TBL] [Abstract][Full Text] [Related]
34. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Ferrari P; Lovati E; Frey FJ J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708 [TBL] [Abstract][Full Text] [Related]
36. Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population. Quinkler M; Bappal B; Draper N; Atterbury AJ; Lavery GG; Walker EA; DeSilva V; Taylor NF; Hala S; Rajendra N; Stewart PM Mol Cell Endocrinol; 2004 Mar; 217(1-2):143-9. PubMed ID: 15134813 [TBL] [Abstract][Full Text] [Related]
37. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system. Seckl JR; Chapman KE Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341 [TBL] [Abstract][Full Text] [Related]
38. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Glorioso N; Filigheddu F; Parpaglia PP; Soro A; Troffa C; Argiolas G; Mulatero P Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035 [TBL] [Abstract][Full Text] [Related]
39. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole. Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598 [TBL] [Abstract][Full Text] [Related]
40. Implication of cortisol and 11beta-hydroxysteroid dehydrogenase enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts. Sunak N; Green DF; Abeydeera LR; Thurston LM; Michael AE Reproduction; 2007 Jun; 133(6):1149-58. PubMed ID: 17636169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]